Sanofi part­ners with Syn­thekine in im­munol­o­gy race

Syn­thekine is team­ing up with Sanofi in a $40 mil­lion-plus col­lab­o­ra­tion to de­vel­op IL-10 re­cep­tor ag­o­nists for au­toim­mune and in­flam­ma­to­ry dis­eases.

The cy­tokine-fo­cused biotech will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER